FDA warns of potential neurological problems associated with Isoxazoline flea and tick products
The Food and Drug Administration (FDA) has issued an alert to pet owners and veterinarians warning of potential neurological problems associated with Isoxazoline flea and tick products. The approved drugs involved are Bravecto, Credelio, Nexgard and Simparica. The warning was issued on the chance animals may experience adverse reactions, including muscle tremors, ataxia, and seizures (which …